However, stopping the medication also means losing the appetite suppression and weight loss benefits
This atrophy and loss of function are often a primary cause of neuropathology, as for example is caused by substantial decreases in expression and function of glutamate transporters in Wernicke-Korsakoff encephalopathy or toxic brain damage
Weight them as individual directional signals, not outcome guarantees
PubMed , Frontiers in Neuroscience , vol
While generally harmless, these bumps can affect how well the medication gets absorbed
Avoid compatibility with chelating agents: If the GHK-Cu is combined with chelating agents such as EDTA, it will be degraded and inactivated, so it should be avoided to use it at the same time with such ingredients